Newsbenzinga
B. Riley Securities Upgrades Capricor Therapeutics to Buy, Raises Price Target to $21
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…